Possibly a request for compassionate use of t-dm1 made by your oncologist directed to company might result in obtaining further information as to how to proceed.
"Genentech® Access to Care Foundation Genentech is committed to helping patients have access to our therapies. For those eligible patients in the United States who do not have insurance coverage or who cannot afford their out-of-pocket co-pay costs, the company provides several
support options through the Genentech Access Solutions program. Since 1985, when our first product was approved, Genentech has donated approximately $1.3 billion in free medicine to uninsured patients through the Genentech® Access to Care Foundation (GATCF) and other charitable programs.
For consideration of eligibility for resources from the Genentech® Access to Care Foundation, the patient must meet eligibility criteria including income restrictions. Please direct requests for applications forms and more specific information on eligibility to:
Genentech Access to Care Foundation
1 DNA Way, MS #13A
South San Francisco, CA 94080
(800) 530-3083
FAX: (650) 225-1366